Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank7
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-81.11M
↓ 127% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-35.78M
Historical baseline
PeriodValueYoY Change
2025$-81.11M+23.6%
2024$-106.15M-97.7%
2023$-53.69M+0.9%
2022$-54.16M-27.8%
2021$-42.38M-91.3%
2020$-22.16M-445.2%
2019$-4.06M-246.5%
2018$2.77M+39.2%
2017$1.99M+70.1%
2016$1.17M-